Atlas Trials

Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia

Clinical trial NCT03679624 · TERMINATED

Trial details

NCT number
NCT03679624
Sponsor
Weill Medical College of Cornell University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Waldenstrom MacroglobulinemiaWaldenstrom's DiseaseWaldenström; HypergammaglobulinemiaWaldenstrom's Macroglobulinemia RecurrentWaldenstrom's Macroglobulinemia of Lymph NodesWaldenstrom's Macroglobulinaemia, Without Mention of RemissionWaldenstrom's Macroglobulinemia Refractory
Start date
2020-07-30
Primary completion
2020-09-15
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.